Continuous glucose monitoring profile in COVID-19 patients with and without diabetes receiving methylprednisolone.

Xingxing HeGuangchen DuanJingyi LuYaxin WangJinghao CaiYiqing TongWei WuXiaojing MaQiming Feng Jian Zhou

Published in: Endocrine (2024)

The impact of methylprednisolone on glycemia was more pronounced in COVID-19 patients without diabetes, compared to those with diabetes. A significant burden of methylprednisolone-induced hyperglycemia was observed in patients without diabetes.

Keyphrases

type diabetes
cardiovascular disease
glycemic control
high dose
end stage renal disease
sars cov
ejection fraction
newly diagnosed
chronic kidney disease
diabetic rats
peritoneal dialysis
prognostic factors
low dose
adipose tissue
risk factors
oxidative stress
metabolic syndrome
skeletal muscle
patient reported